Effects of nicotine on head-shakes and tryptophan metabolites

Psychopharmacology

Volumn 153, Issue 3, 2001, Pages 327-333

  Gaynor, C M ^a   Handley, S L ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cholinergic nicotinic receptor; Head shakes; Kynurenine; Nicotine; Tryptophan

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 3 HYDROXYKYNURENINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; EPIBATIDINE; KYNURENIC ACID; KYNURENINE; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GILLES DE LA TOURETTE SYNDROME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPTOPHAN METABOLISM;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; HEAD MOVEMENTS; HYDROXYINDOLEACETIC ACID; INDOPHENOL; KYNURENINE; MALE; MICE; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; SEROTONIN; SEROTONIN AGONISTS; TICS; TRYPTOPHAN;

EID: 0035142988     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000558     Document Type: Article

References (37)

1. Epibatidine, a potent analgesic and nicotinic agonist
2. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles
3. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity
4. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain
5. Factors modifying the head-twitch response to 5-hydroxytryptophan
6. Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: A dose-response and antagonist study
7. Elevated plasma kynurenine in Tourette syndrome
8. Long-lasting improvement of Tourette's syndrome with transdermal nicotine
9. Increased plasma kynurenine in Tourette syndrome may be due to induction of IDO
10. Serotonin and Tourette's syndrome: Movements such as head-shakes and wet-dog shakes may model human tics
11. The interaction of some kynurenine pathway metabolites with 5-hydroxytryptophan and 5-hydroxytryptamine
12. Neurotransmitters and shaking behaviour - More than a "gut-bath" for the brain?
13. Ritanserin reduces morphine, and clonidine, withdrawal tics
14. 2-adrenoceptors in rat brain after short-term DSP-4 lesioning
15. Quantification of kynurenic acid in cerebrospinal fluid: Effects of systemic and central L-kynurenine administration
16. Quinolinic acid inhibits DOI-induced head shakes in mice
17. 1A receptor binding affinity in mouse cerebral cortex
18. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia
19. Tolerance, cross-tolerance and receptors after chronic nicotine or oxotremorine
20. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors
21. Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder
22. Kynurenine potentiates the DOI headshake in mice
23. Effect of long-term nicotine treatment on [3H]nicotine binding sites in the rats brain
24. Chronic nicotine exposure differentially affects the function of human alpha 3, alpha 4, and alpha 7 neuronal nicotinic receptor subtypes
25. Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection. Increased concentration in hepatic encephalopathy
26. Effects of systemic nicotine on serotonin release in rat brain
27. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome
28. 3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs
29. Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography
30. Nicotine blocks kainic acid-induced wet dog shakes in rats
31. Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome
32. Case study: Long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome
33. (±)-epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic, acetylcholine receptors
34. Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorimetric and coulometric electrode array detection
35. Brain nicotine binding sites